📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
CONCORD DRUGS LIMITEDCONCORDPharmaceuticals
Open
70.23
High
72.7
Low
68
Close
70.64
Volume
2019
Exchange
bse
Time
01-Apr-2026

Outlook

Score:  

0.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Concord Drugs is  
Spinning Top
Estimated Stoploss of Concord Drugs is ₹  
68
Concord Drugs has a  
Bullishℹ
 pattern. 
Formation of  
Spinning Top
 candle pattern indicates the trend direction of Concord Drugs is  
Unpredictableℹ
. 

Trend

Concord Drugs is in  
Sideways trendℹ
. 
Price of Concord Drugs is  
Downℹ
 by  

7.32

%. 
Target
Buy @ 

67.21

Sell @ 

88.77

Current @ 

70.64

Volume

The trade volumes of Concord Drugs have become  
Deficientℹ
The volume trend for Concord Drugs is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Concord Drugs is  

Down

 by  

75.07

% 

Valuation

The current market price of Concord Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 65cr and total assets worth ₹ 65cr, the balance sheet of Concord Drugs is:  
Balancedℹ
. 
Cashflow
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 3cr earned in operatingℹ
33.33% i.e. ₹ 2cr spent in investingℹ
16.67% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Concord Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

0% in operatingℹ
100% i.e. ₹ 1cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Concord Drugs Losses increased by:  

0

% and Income is Down by:  

23.08

% 

(*Sep 2025)

The income of Concord Drugs is  

₹ 13cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

30

% 

(*Jun 2025)

The income of Concord Drugs is  

₹ 10cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Concord Drugs Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.